Entering text into the input field will update the search result below

Puma Biotechnology, Inc. (PBYI) CEO Alan Auerbach on Q1 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET

Company Participants

Mariann Ohanesian - Senior Director, IR

Alan Auerbach - Founder, Chairman, President, CEO & Secretary

Jeff Ludwig - Chief Commercial Officer

Maximo Nougues - CFO & Principal Accounting Officer

Conference Call Participants

Carly Kenselaar - Citigroup

Marc Frahm - Cowen and Company

Kennen MacKay - RBC Capital Markets

Alec Stranahan - Bank of America Merrill Lynch

Sheldon Fan - Barclays Bank


Good afternoon. My name is Kevin, and I'll be your conference call operator today. [Operator Instructions]. As a reminder, this call is being recorded.

I would now like to turn the call over to Mariann Ohanesian, Senior Director of IR for Puma Biotechnology. You may begin your conference.

Mariann Ohanesian

Thank you, Kevin. Good afternoon, and welcome to Puma's conference call to discuss our financial results for the first quarter of 2021. Joining me on the call today are Alan Auerbach, Chief Executive Officer, President and Chairman of the Board of Puma Biotechnology; Maximo Nougues, Chief Financial Officer; and Jeff Ludwig, Chief Commercial Officer.

After market closed today, Puma issued a news release detailing first quarter 2021 financial results. That news release, the slides that Jeff will refer to and a webcast of this call, are accessible via the homepage and Investors sections of our website at pumabiotechnology.com. The webcast and presentation slides will be archived on our website and available for the reply for the next 90 days.

Today's conference call will include statements about the company's future expectations, plans and prospects that constitute forward-looking statements for purposes of federal securities laws. Such statements are subject to risks and uncertainties, and actual events and results may differ from those expressed in these forward-looking statements. For a full discussion of these risks and uncertainties, please review

Recommended For You

Comments (1)

What a dog … same BS over and over again. There is no growth with this company
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.